CJ CheilJedang Responds to Bio Division Sale Reports: "Reviewing Various Strategic Options"
CJ CheilJedang announced on the 19th that it is "reviewing various strategic options" regarding reports of the sale of its bio business division, and that "no decisions have been made yet."
In response to an inquiry disclosure request about the report, CJ CheilJedang stated, "We are reviewing various strategic options for the bio business, but no specific decisions have been made so far."
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Withdrew 1.2 Billion Won from Husband's Account Just Before Death"...Remarried Wife Receives Suspended Prison Sentence
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
They added, "We will re-disclose the information when specific details are decided or within one month." The scheduled date for the re-disclosure is the 18th of next month.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
